Levitee Labs Announces Important Partnership Recently, Levitee Labs has gained some recognition in the media for the announcement of its partnership with LiveRx research group to provide Hepatitis C patients with better access to quality treatment. This is an important partnership for $LVT, as it is expanding the Levitee Clinic service area to a wider variety of people, and therefore increase their revenue streams.
They are trading at $0.32 per share with a market cap of 25 Million.
Check out the full story here: https://leviteelabs.com/levitee-labs-announces-strategic-partnership-with-liverx-research-group-to-provide-equitable-access-to-hepatitis-c-care-throughout-alberta-canada/